Biopolym. Cell. 1999; 15(4):314-318.
Viruses and Cell
The effect of trimeric 2',5'-oligoadenylic acid and its epoxyderivative on the human immunodeficiency virus reproduction and retroviruses reverse transcriptase activity
- Institute of Molecular Biology and Genetics, NAS of Ukraine
150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03680 - Gromashevsky L.V. Institute of Epidemiology and Infection Diseases, AMS of Ukraine
5, Amosova Str., Kyiv, Ukraine, 03038 - R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, NAS of Ukraine
45, Vasilkivska Str., Kyiv, Ukraine, 01022 - Institute of Bioorganic Chemistry, NAS of Belarus
5/2, Kuprevich Str., Minsk, Republic of Belarus, 220141
Abstract
The study of the effect of trimeric 2',5'-oligoadenytic acid (2',5'ApApA) and its epoxyderivative (2',5'-A2(RAA)) on both human immunodeficiency virus (HIV-1) reproduction and retro-viruses reverse transcriptase activity was conducted. 2',5'-oligo-adenylates were shown to suppress HIV-1 reproduction in case of their pre-incubation with the lymphoblastoid cells of MT-4 line. The possible mechanisms of antivirial action of 2' ,5'-oligoadenylates were under investigation, in particular, the interferonogenic effect of the substances was examined. 2',5'ApApA and 2',5'-A2(RAA) were shown to increase amounts of interferon in cells two and four-fold respectively compared to control. The inhibitory effect of 2',5'-oligoadenylates on activity of endogenous and exogenous retroviruses reverse transcriptase was demonstrated. The trimeric 2',5'-oligoadenylic acid and its epoxyderivative may be used against HIV infection.
Full text: (PDF, in Ukrainian)
References
[1]
Muller WE, Schrodeer HC. Alteration of (2'-5')oligoadenylatee metabolism and ribonuclease L activity in H-9 cells by HIV. Int. Conf. AIDS., 1989 p. 667.
[2]
Schroder HC, Wenger R, Kuchino Y, Muller WE. Modulation of nuclear matrix-associated 2',5'-oligoadenylate metabolism and ribonuclease L activity in H9 cells by human immunodeficiency virus. J Biol Chem. 1989;264(10):5669-73.
[3]
Veda M, Higasa S, Suehiro A, Kakishita E. Evaluation of immuno-status in HIV disease using serum 2',5'-oligoadenylate synthetase activity. Int. Conf. AIDS., 1994; 10(1):158.
[4]
Schroder HC, Kelve M, Muller WE. The 2-5A system and HIV infection. Prog Mol Subcell Biol. 1994;14:176-97.
[5]
Schroder HC1, Suhadolnik RJ, Pfleiderer W, Charubala R, M?ller WE. (2'-5')Oligoadenylate and intracellular immunity against retrovirus infection. Int J Biochem. 1992;24(1):55-63.
[6]
Mikhailopulo IA, Baran EA, Tkachuk LV. Synthesis and use in kidney transplantations in rabbits and monkeys of (2-5')oligoadenylate trimers modified at the 2'-terminus. 4th Int. symp. on Molecular aspects of chemotherapy, (23-25 June, 1993, Gdansk).-Gdansk 1993 p. 61.
[7]
Viscidi R, Farzadegan H, Leister F, Francisco ML, Yolken R. Enzyme immunoassay for detection of human immunodeficiency virus antigens in cell cultures. J Clin Microbiol. 1988;26(3):453-8.
[8]
Soloviev VD Pektemirov TA. Interferons in theory and practice meditsiny. M.: Medicine, 1981:85-90.
[9]
Liu DK, Owens GF. Inhibition of viral reverse transcriptase by 2',5'-oligoadenylates. Biochem Biophys Res Commun. 1987;145(1):291-7.
[10]
Kozlov AV, Tkachuk ZYu. Study of 2', 5'-oligoadenylates analogues stability to the action of phosphodiesterases Biopolym. Cell. 1994; 10(1):47-52
[11]
Montefiori DC, Sobol RW Jr, Li SW, Reichenbach NL, Suhadolnik RJ, Charubala R, Pfleiderer W, Modliszewski A, Robinson WE Jr, Mitchell WM. Phosphorothioate and cordycepin analogues of 2',5'-oligoadenylate: inhibition of human immunodeficiency virus type 1 reverse transcriptase and infection in vitro. Proc Natl Acad Sci U S A. 1989;86(18):7191-4.
[12]
Sobol RW, Fisher WL, Reichenbach NL, Kumar A, Beard WA, Wilson SH, Charubala R, Pfleiderer W, Suhadolnik RJ. HIV-1 reverse transcriptase: inhibition by 2',5'-oligoadenylates. Biochemistry. 1993;32(45):12112-8.